| A systematic review of animal models of NAFLD finds high‐fat, high‐fructose diets most closely resemble human NAFLD YR Im, H Hunter, D de Gracia Hahn, A Duret, Q Cheah, J Dong, M Fairey, ... Hepatology 74 (4), 1884-1901, 2021 | 102 | 2021 |
| rs641738C> T near MBOAT7 is associated with liver fat, ALT and fibrosis in NAFLD: A meta-analysis K Teo, KWM Abeysekera, L Adams, E Aigner, QM Anstee, JM Banales, ... Journal of hepatology 74 (1), 20-30, 2021 | 100 | 2021 |
| Machine learning for workflow applications in screening mammography: systematic review and meta-analysis SE Hickman, R Woitek, EPV Le, YR Im, C Mouritsen Luxhøj, ... Radiology 302 (1), 88-104, 2022 | 69 | 2022 |
| Next-generation liquid biopsies: embracing data science in oncology YR Im, DWY Tsui, LA Diaz, JCM Wan Trends in cancer 7 (4), 283-292, 2021 | 46 | 2021 |
| Beyond PPE: a mixed qualitative–quantitative study capturing the wider issues affecting doctors’ well-being during the COVID-19 pandemic LJ Cubitt, YR Im, CJ Scott, LC Jeynes, PD Molyneux BMJ open 11 (3), e050223, 2021 | 45 | 2021 |
| Prevalence of occult hepatitis B virus infection in adults: a systematic review and meta-analysis YR Im, R Jagdish, D Leith, JU Kim, K Yoshida, A Majid, Y Ge, G Ndow, ... The Lancet Gastroenterology & Hepatology 7 (10), 932-942, 2022 | 29 | 2022 |
| Weight loss, insulin resistance, and study design confound results in a meta-analysis of animal models of fatty liver H Hunter, D de Gracia Hahn, A Duret, YR Im, Q Cheah, J Dong, M Fairey, ... Elife 9, e56573, 2020 | 9 | 2020 |
| Autoimmunity Due to Unicentric Castleman Disease Cured by Resection of a Hepatic Mass YR Im, J Dong, AL Paterson, S Harper, J Peters JCR: Journal of Clinical Rheumatology 27 (1), e32-e33, 2019 | 3 | 2019 |
| Systematic review of randomised controlled trials on interventions aimed at promoting colorectal cancer screening amongst ethnic minorities SNB Abdul Latip, SE Chen, YR Im, AP Zielinska, N Pawa Ethnicity & Health 28 (5), 661-695, 2023 | 2 | 2023 |
| Insights into paediatric non-alcoholic fatty liver disease from genetic variants. J Dong, YR Im, JP Mann Wiley, 2019 | 2 | 2019 |
| The intricacies of the Mediterranean diet in NAFLD A Duret, D de Gracia Hahn, H Hunter, YR Im, JP Mann Official journal of the American College of Gastroenterology| ACG 113 (5), 775, 2018 | 2 | 2018 |
| A systematic analysis of rodent models implicates adipogenesis and innate immunity in pathogenesis of fatty liver disease YR Im, H Hunter, D de Gracia Hahn, A Duret, Q Cheah, J Dong, M Fairey, ... bioRxiv, 2020.12. 15.422799, 2020 | 1 | 2020 |
| THE EFFICACY OF ANTIVIRAL THERAPY AT PREVENTING CLINICAL OUTCOMES IN HBV-INFECTED PEOPLE AT DIFFERENT BASELINE VIRAL LOAD AND ALT LEVELS: A GLOBAL SYSTEMATIC REVIEW & META-ANALYSIS YR Im, SE Chen, R Jagdish, D Yucuma, A Rakover, ZI Warsop, R Chou, ... HEPATOLOGY 78, S548-S549, 2023 | | 2023 |
| THE NATURAL HISTORY OF CHRONIC HBV INFECTION ACCORDING TO HBV DNA & ALT LEVELS AT BASELINE: A GLOBAL SYSTEMATIC REVIEW & METAANALYSIS ZI Warsop, A Rakover, D Yucuma, YR Im, SE Chen, R Jagdish, R Chou, ... HEPATOLOGY 78, S498-S499, 2023 | | 2023 |
| Estimations of the global prevalence and clinical burden of occult hepatitis B infection (OBI): a systematic review and meta-analysis YR Im, R Jagdish, D Leith, JU Kim, G Ndow, K Yoshida, A Majid, Y Ge, ... Journal of Hepatology 77, S290-S291, 2022 | | 2022 |
| NAFLD Animal Models database YR Im, A Duret, H Hunter, JP Mann | | 2021 |
| Time to discharge from the two-week wait colorectal pathway: A quality improvement project C Edwin, N Patell, M Ward, N Yang, Y Im, N Pawa Colorectal Disease, 115-115, 2021 | | 2021 |
| Ethnicity is a missing parameter in colorectal cancer screening programmes in the United Kingdom YR Im, SNBA Latip, AP Zielinska, N Pawa Public health 190, e14-e15, 2020 | | 2020 |
| Subcortical dementia YR Im | | 2015 |
| Ebola 2014 YR Im, C Reeves, MV Maddox | | |
Jake P MannUniversity of Birmingham (j.p.mann [at] bham.ac.uk)Adresse e-mail validée de nhs.net
